|Mar 24, 2017|
|Mar 24, 2017|
Currency in KRW
|Full time employees:||--|
KT&G Corp. engages in the manufacture and sale of tobacco products. It operates through the following business divisions: Tobacco, Health Functional Food, Foods, Tobacco Leaf, Pharmaceuticals, Tobacco Materials, Trading and Real Estates. The Health Functional Food division manufactures and sells red ginseng, red ginseng products and healthy foods. The Foods division provides groceries and beverages. The Tobacco Leaf division engages in the cultivation of tobacco leaf lands. The Pharmaceutical division manufactures and sells drugs, biotech drugs, non-pharmaceutical health complements, other related products, medical goods and equipments. The Tobacco Materials division engages in the manufacture and distribution of raw materials needed in production of tobacco. The Real Estates division offers rentals, sales and housing development. It was founded on April 1, 1987 and is headquartered in Daejeon, South Korea.
KT&G was founded as Korea Monopoly by the South Korean government in 1987. It was later privatized and listed on the South Korean stock market in 1999. It took its current name in 2002. The ginseng business was spun off to form a wholly owned subsidiary, Korea Ginseng.
Because KT&G produces tobacco and ginseng, one might expect the company name to stand for Korea Tobacco & Ginseng; however, it officially stands for Korea Tomorrow & Global.
KT&G no longer gets direct investment from the government; instead, government-affiliated small and midsize banks and national pension funds own stakes in it. It is known in South Korea as a company in which foreign investors have sizable interests.
The bulk of the company's earnings come from its tobacco business, which sells brands such as Esse, Bohem, This and Pine. The South Korean cigarette market has been contracting over the medium term as a smoking ban has been expanded both indoors and outdoors due to health concerns, and prices were raised sharply in 2015.
Sales abroad, on the other hand, are on the rise. The company is boosting exports and producing tobacco in Indonesia, Turkey, Russia and Iran.
KT&G also sells ginseng-based health food and beverages. Ginseng is commonly used as an ingredient for pharmaceuticals.
In the news
KT&G's profit margin exceeds 40%
March 15, 2017 5:30 am JST
December 28, 2016 8:34 pm JST
July 7, 2016 12:00 pm JST
June 16, 2016 12:00 pm JST
Innovative medical tech
November 13, 2015 3:01 pm JST
October 23, 2015 9:26 am JST
October 22, 2015 11:47 pm JST
- Local currency
- US Dollar
|Income before tax||1,585.76B|
|Dividends per share||3,600|
|Operating cash flow||1,547.34B|
Currency in KRW
|Income before tax||1,366.81M|
|Dividends per share||3.10|
|Operating cash flow||1,333.70M|
Currency in USD
- President & Chief Executive Officer: Bok-In Baek
- Managing Director & Head-Finance Division: Gyeong-Bo Kang
- Managing Director, Head-Research & Development: Chang-Hyo Lee
- Director & Vice President: Heung-Ryeol Kim
- Executive Director: Jeong-Sik Jang
- National Pension Service of Korea(8.7%)
- KT&G Corp.(8.0%)
- Industrial Bank of Korea(6.9%)
- First Eagle Investment Management LLC(3.9%)
- Deutsche Asset Management Investment GmbH(2.5%)
- Japan Tobacco Inc.(2.0%)
- KT&G Corp. Employee Stock Ownership Association(2.0%)
- BlackRock Fund Advisors(1.8%)
- Thornburg Investment Management, Inc.(1.7%)
- The Vanguard Group, Inc.(1.7%)
- Website: http://www.ktng.com
- Address: 71 Beotkkot-gil, Daedeok-gu, Daejeon, 34337, South Korea
- Phone: +82.42.939.5000
Copyright © 2017 FactSet Research Systems Inc. All rights reserved.